Organon & Co
Held by 2 superinvestors (OGN).
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Organon & Co (OGN) is held by 2 of the superinvestors tracked on Compounder, with a combined $36.7M in reported 13F value. The largest position belongs to Thomas Kahn, where it makes up 5.9% of the portfolio.
Other notable holders by value include Ray Dalio (0.0% of its book).
Over the latest quarter, 0 of the tracked filers opened a new position in OGN, 1 added to existing ones, 1 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
Superinvestors holding this security over the last 8 quarters: 2 → 2.
Early quarters may understate holder counts due to data backfill — read the slope with care.
- Value$33.2MWeight (prev→now)4.6% → 5.9% ▲
- Value$3.6MWeight (prev→now)0.0% → 0.0% ▼
Sources· SEC EDGAR 13F as of 2026-05-15
Related
Stay Updated
Curated 13F moves and valuation insights, straight to your inbox.